- Home
- DSGN vs OBE Comparison
DSGN vs OBE Comparison
Compare DSGN & OBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DSGN | OBE |
|---|---|---|
| Founded | 2017 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.9M | 526.9M |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | DSGN | OBE |
|---|---|---|
| Price | $10.28 | $8.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $15.25 | $10.00 |
| AVG Volume (30 Days) | 242.4K | ★ 651.7K |
| Earning Date | 03-09-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $20.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $3.88 |
| 52 Week High | $11.23 | $8.90 |
Technical Indicators
Market Signals| Indicator | DSGN | OBE |
|---|---|---|
| Relative Strength Index (RSI) | 50.78 | 62.43 |
| Support Level | $9.64 | $5.51 |
| Resistance Level | $11.14 | $8.90 |
| Average True Range (ATR) | 0.59 | 0.33 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 42.21 | 69.01 |
Price Performance
Historical ComparisonAbout DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About OBE Obsidian Energy Ltd.
Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Sale of Oil.